Related Experiment Video
Updated: May 2, 2026

12:21
MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
14.2K
MicroRNA signature and function in retinal neovascularization
Saloni Agrawal1, Brahim Chaqour1
1Saloni Agrawal, Department of Cell Biology, State University of New York (SUNY) Downstate Medical Center, Brooklyn, NY 11203, United States.
World Journal of Biological Chemistry
|March 7, 2014
Summary
MicroRNAs (miRNAs) offer a promising therapeutic strategy for ischemic retinopathies by targeting the angiogenic pathway. Understanding miRNA regulation is key to developing effective treatments for ocular neovascular diseases.
Area of Science:
- Ophthalmology
- Molecular Biology
- Genetics
Background:
- Ischemic retinopathies involve retinal microvascular damage and aberrant neovascularization.
- These conditions are exacerbated by factors like diabetes, aging, and inflammation.
- Current therapies may require targeting multiple aspects of the angiogenic pathway.
Purpose of the Study:
- To review the role of microRNAs (miRNAs) in regulating angiogenesis.
- To explore the potential of miRNA-based therapies for ocular neovascular diseases.
- To highlight recent findings on angiogenic and antiangiogenic miRNAs and their gene targets.
Main Methods:
- Literature review focusing on miRNA-gene target networks.
- Analysis of miRNA involvement in vascular cell signaling and blood vessel formation.
- Synthesis of current knowledge on miRNA regulation in ocular neovascularization.
Main Results:
- Specific miRNAs regulate vascular cell responses by targeting key factors, receptors, and signaling molecules.
- miRNAs play a crucial role in maintaining or disrupting vascular function.
- Progress has been made in mapping miRNA-gene interactions and gene expression control.
Conclusions:
- miRNA-based therapy presents a rational approach for antiangiogenic treatment in ischemic retinopathies.
- Further research into miRNA specificity, turnover, transport, and sequence modification is needed.
- Enhanced understanding of miRNAs will improve their therapeutic utility in treating ocular neovascular diseases.
Related Concept Videos
MicroRNAs
21.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs
9.8K
9.8K

